Pitt Names Edward P. Krenzelok Inaugural Dr. Gordon J. Vanscoy Chair of Pharmacy

Issue Date: 
January 20, 2009

Edward P. Krenzelok has been named the inaugural Dr. Gordon J. Vanscoy Chair of Pharmacy at the University of Pittsburgh School of Pharmacy. Krenzelok is a Pitt professor of pharmacy and pediatrics and director of the Pittsburgh Poison Center and Drug Information Center at UPMC

The $1.5 million endowment was established by Gordon J. Vanscoy (KGSB ’91, SHRS ’84),chairman and chief executive officer of University Pharmacotherapy Associates LLC, associate dean of business innovation, and associate professor of pharmacy and therapeutics at the University of Pittsburgh School of Pharmacy.

“I’ve been fortunate to enjoy success in my career and want to give back to the university by investing in a person who will serve as an ambassador for both the pharmacy profession and the University of Pittsburgh,” said Vanscoy, a Pitt graduate. “Ed Krenzelok fits this description and I’m thrilled that he has been selected as the inaugural chair.”

Krenzelok, a 25-year faculty member at the School of Pharmacy, plans to focus his efforts on promoting the importance of poison and drug resources throughout the University.

“I’m honored to serve as the Dr. Gordon J. Vanscoy Chair,” Krenzelok said. “I’m looking forward to serving the school and the profession as an advocate for research that helps to validate the importance and accessibility of poison and drug information resources to all health care professionals.”

Krenzelok is board-certified in clinical toxicology by the American Board of Applied Toxicology and is a fellow in the American Academy of Clinical Toxicology. He serves on the Board of Directors of the American Association of Poison Control Centers, on the editorial boards and review panels of numerous medical journals, and is the author of several hundred scientific publications and book chapters.

Krenzelok was chair of the United States Pharmacopeia Clinical Toxicology and Drug Expert Committee, a former member of the Food and Drug Administration Nonprescription Drug Advisory Committee, and past president of the American Academy of Clinical Toxicology.